Brighton Jones’s Cardiff Oncology CRDF Stock Holding History
Bought
Maintained
Sold
Other funds holding CRDF
Brighton Jones's CRDF Position: Q3 2026 in Review
Brighton Jones reduced its Cardiff Oncology (CRDF) stake by 18% in Q3 2026, selling an estimated $3.98K and leaving 16,741 shares worth $20.3K. The position accounts for ﹤0.01% of the portfolio, ranked #1381.
Brighton Jones first reported a position in CRDF in Q1 2025 and has held it in 6 quarters since. The position peaked at $52K in Q2 2025. 66 funds tracked by Wall St. Rank hold CRDF as of Q3 2026.
- Brighton Jones held 16,741 shares of Cardiff Oncology worth $20.3K as of Q3 2026.
- Brighton Jones sold 3,712 Cardiff Oncology shares in Q3 2026, an estimated $3.98K.
- Cardiff Oncology made up ﹤0.01% of Brighton Jones's portfolio in Q3 2026, its #1381 holding.
- Brighton Jones first reported a position in Cardiff Oncology in Q1 2025 and has held it in 6 quarters since.
- Brighton Jones's Cardiff Oncology position peaked at $52K in Q2 2025.
- 66 funds tracked by Wall St. Rank held Cardiff Oncology as of Q3 2026.
Based on Brighton Jones's 13F filing for Q3 2026, filed 3 Nov 2026.